Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.

Identifieur interne : 000393 ( Main/Merge ); précédent : 000392; suivant : 000394

Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.

Auteurs : S. King [Royaume-Uni] ; K. Adjei-Asante ; L. Appiah ; D. Adinku ; A. Beloukas ; M. Atkins ; S F Sarfo ; D. Chadwick ; R O Phillips ; A M Geretti

Source :

RBID : pubmed:25394987

Descripteurs français

English descriptors

Abstract

HIV coinfection with HCV has been poorly studied in sub-Saharan Africa, and the reliability of available seroprevalence estimates remains uncertain. The study aim was to determine HCV RNA prevalence in HIV-infected subjects receiving care in Kumasi, Ghana, and relate the findings to HCV antibody detection. From a population of 1520 HIV-infected adults, all HBsAg-positive subjects (n = 236) and a random subset of HBsAg-negative subject (n = 172) were screened for HCV RNA using pooled plasma; positive samples were genotyped by core and NS5B sequencing. HCV antibodies were detected by three commercial screening assays and confirmed by the line immunoassay. HCV RNA was detected in 4/408 subjects (1.0%, 95% confidence interval 0.0-1.9%), comprising 3/236 (1.3%; 0.0-2.8%) HBsAg-positive and 1/172 (0.6%; 0.0-1.8%) HBsAg-negative subjects. HCV RNA-positive subjects showed reactivity in all three antibody screening assays. Among HCV RNA-negative subjects, 5/67 (7.5%), 5/67 (7.5%) and 19/67 (28.4%) showed antibody reactivity by each screening assay, respectively, including two (3.0%) with reactivity by all three assays. Only one sample (1.5%) had confirmed antibody reactivity by line immunoassay indicating past HCV infection. HCV-positive subjects (three males, two females) were aged 30-46 years, by questionnaire-based interview reported surgical procedures and blood transfusion as risk factors for infection. HCV genotypes were 2 (subtypes 2j, 2l, 2k/unassigned) and 1 (subtype unassigned). Without further testing, HCV antibody screening assays variably overestimated HCV prevalence among HIV-infected subjects in Ghana. These findings inform the interpretation of previous seroprevalence estimates based upon screening assays alone.

DOI: 10.1111/jvh.12354
PubMed: 25394987

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:25394987

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.</title>
<author>
<name sortKey="King, S" sort="King, S" uniqKey="King S" first="S" last="King">S. King</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Infection and Global Health, University of Liverpool, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Adjei Asante, K" sort="Adjei Asante, K" uniqKey="Adjei Asante K" first="K" last="Adjei-Asante">K. Adjei-Asante</name>
</author>
<author>
<name sortKey="Appiah, L" sort="Appiah, L" uniqKey="Appiah L" first="L" last="Appiah">L. Appiah</name>
</author>
<author>
<name sortKey="Adinku, D" sort="Adinku, D" uniqKey="Adinku D" first="D" last="Adinku">D. Adinku</name>
</author>
<author>
<name sortKey="Beloukas, A" sort="Beloukas, A" uniqKey="Beloukas A" first="A" last="Beloukas">A. Beloukas</name>
</author>
<author>
<name sortKey="Atkins, M" sort="Atkins, M" uniqKey="Atkins M" first="M" last="Atkins">M. Atkins</name>
</author>
<author>
<name sortKey="Sarfo, S F" sort="Sarfo, S F" uniqKey="Sarfo S" first="S F" last="Sarfo">S F Sarfo</name>
</author>
<author>
<name sortKey="Chadwick, D" sort="Chadwick, D" uniqKey="Chadwick D" first="D" last="Chadwick">D. Chadwick</name>
</author>
<author>
<name sortKey="Phillips, R O" sort="Phillips, R O" uniqKey="Phillips R" first="R O" last="Phillips">R O Phillips</name>
</author>
<author>
<name sortKey="Geretti, A M" sort="Geretti, A M" uniqKey="Geretti A" first="A M" last="Geretti">A M Geretti</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25394987</idno>
<idno type="pmid">25394987</idno>
<idno type="doi">10.1111/jvh.12354</idno>
<idno type="wicri:Area/PubMed/Corpus">000113</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000113</idno>
<idno type="wicri:Area/PubMed/Curation">000113</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000113</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000113</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000113</idno>
<idno type="wicri:Area/Ncbi/Merge">000726</idno>
<idno type="wicri:Area/Ncbi/Curation">000726</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000726</idno>
<idno type="wicri:Area/Main/Merge">000393</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.</title>
<author>
<name sortKey="King, S" sort="King, S" uniqKey="King S" first="S" last="King">S. King</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Infection and Global Health, University of Liverpool, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Adjei Asante, K" sort="Adjei Asante, K" uniqKey="Adjei Asante K" first="K" last="Adjei-Asante">K. Adjei-Asante</name>
</author>
<author>
<name sortKey="Appiah, L" sort="Appiah, L" uniqKey="Appiah L" first="L" last="Appiah">L. Appiah</name>
</author>
<author>
<name sortKey="Adinku, D" sort="Adinku, D" uniqKey="Adinku D" first="D" last="Adinku">D. Adinku</name>
</author>
<author>
<name sortKey="Beloukas, A" sort="Beloukas, A" uniqKey="Beloukas A" first="A" last="Beloukas">A. Beloukas</name>
</author>
<author>
<name sortKey="Atkins, M" sort="Atkins, M" uniqKey="Atkins M" first="M" last="Atkins">M. Atkins</name>
</author>
<author>
<name sortKey="Sarfo, S F" sort="Sarfo, S F" uniqKey="Sarfo S" first="S F" last="Sarfo">S F Sarfo</name>
</author>
<author>
<name sortKey="Chadwick, D" sort="Chadwick, D" uniqKey="Chadwick D" first="D" last="Chadwick">D. Chadwick</name>
</author>
<author>
<name sortKey="Phillips, R O" sort="Phillips, R O" uniqKey="Phillips R" first="R O" last="Phillips">R O Phillips</name>
</author>
<author>
<name sortKey="Geretti, A M" sort="Geretti, A M" uniqKey="Geretti A" first="A M" last="Geretti">A M Geretti</name>
</author>
</analytic>
<series>
<title level="j">Journal of viral hepatitis</title>
<idno type="eISSN">1365-2893</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Female</term>
<term>Genotype</term>
<term>Genotyping Techniques</term>
<term>Ghana (epidemiology)</term>
<term>HIV Infections (complications)</term>
<term>Hepatitis C (diagnosis)</term>
<term>Hepatitis C (epidemiology)</term>
<term>Hepatitis C Antibodies (blood)</term>
<term>Humans</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>RNA, Viral (blood)</term>
<term>Sequence Analysis, DNA</term>
<term>Seroepidemiologic Studies</term>
<term>Serologic Tests</term>
<term>Viral Core Proteins (genetics)</term>
<term>Viral Nonstructural Proteins (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN viral (sang)</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de séquence d'ADN</term>
<term>Anticorps de l'hépatite C (sang)</term>
<term>Dépistage systématique</term>
<term>Femelle</term>
<term>Ghana (épidémiologie)</term>
<term>Génotype</term>
<term>Humains</term>
<term>Hépatite C (diagnostic)</term>
<term>Hépatite C (épidémiologie)</term>
<term>Infections à VIH ()</term>
<term>Mâle</term>
<term>Protéines du core viral (génétique)</term>
<term>Protéines virales non structurales (génétique)</term>
<term>Techniques de génotypage</term>
<term>Tests sérologiques</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Hepatitis C Antibodies</term>
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Ghana</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Hépatite C</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Viral Core Proteins</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Protéines du core viral</term>
<term>Protéines virales non structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>ARN viral</term>
<term>Anticorps de l'hépatite C</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Ghana</term>
<term>Hépatite C</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Female</term>
<term>Genotype</term>
<term>Genotyping Techniques</term>
<term>Humans</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>Sequence Analysis, DNA</term>
<term>Seroepidemiologic Studies</term>
<term>Serologic Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de séquence d'ADN</term>
<term>Dépistage systématique</term>
<term>Femelle</term>
<term>Génotype</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Mâle</term>
<term>Techniques de génotypage</term>
<term>Tests sérologiques</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">HIV coinfection with HCV has been poorly studied in sub-Saharan Africa, and the reliability of available seroprevalence estimates remains uncertain. The study aim was to determine HCV RNA prevalence in HIV-infected subjects receiving care in Kumasi, Ghana, and relate the findings to HCV antibody detection. From a population of 1520 HIV-infected adults, all HBsAg-positive subjects (n = 236) and a random subset of HBsAg-negative subject (n = 172) were screened for HCV RNA using pooled plasma; positive samples were genotyped by core and NS5B sequencing. HCV antibodies were detected by three commercial screening assays and confirmed by the line immunoassay. HCV RNA was detected in 4/408 subjects (1.0%, 95% confidence interval 0.0-1.9%), comprising 3/236 (1.3%; 0.0-2.8%) HBsAg-positive and 1/172 (0.6%; 0.0-1.8%) HBsAg-negative subjects. HCV RNA-positive subjects showed reactivity in all three antibody screening assays. Among HCV RNA-negative subjects, 5/67 (7.5%), 5/67 (7.5%) and 19/67 (28.4%) showed antibody reactivity by each screening assay, respectively, including two (3.0%) with reactivity by all three assays. Only one sample (1.5%) had confirmed antibody reactivity by line immunoassay indicating past HCV infection. HCV-positive subjects (three males, two females) were aged 30-46 years, by questionnaire-based interview reported surgical procedures and blood transfusion as risk factors for infection. HCV genotypes were 2 (subtypes 2j, 2l, 2k/unassigned) and 1 (subtype unassigned). Without further testing, HCV antibody screening assays variably overestimated HCV prevalence among HIV-infected subjects in Ghana. These findings inform the interpretation of previous seroprevalence estimates based upon screening assays alone.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000393 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000393 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:25394987
   |texte=   Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:25394987" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024